Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Mass spectrometry proteomic analysis of PTPN12 to elucidate its phosphatase role in tumor suppression and cell signalling
FY 2012-13
Summary
PTPN12 is a phosphatase protein can cause cells to become tumorigenic when it is not working properly. It is found to be defective in patients with triple negative breast cancer, a type of breast cancer disease that is not easily identified by specific biomarkers and affects 20% of breast cancer patients. In addition, this particular breast cancer is highly aggressive and resistant to treatment. Better understanding of PTPN12 and its function in cellular biology will allow elucidation on how normal cells become cancerous. This project will focus primarily on triple negative breast cancer but the information gleaned from the research could very well apply to other cancers as well.
One method to determine how PTPN12 functions in cellular biology is to see what other proteins it affects and interacts with. To do this, we apply a new technique called BioID that fused our protein of interest with a biotin ligase. This protein essentially allows neighbouring proteins of PTPN12 to be covalently linked with a biotin molecule. This physical linkage allows the proteins, which are those that interact with PTPN12, to be isolated and from the cell using streptavidin, which binds to biotin molecules with extremely high affinity. The purified proteins are then subjected to mass spectrometry analysis to identify them. This method allows the discovery of new, unknown proteins that were not reported to interact with PTPN12. Early results show that this method identifies known protein interactors from an established purification method that the Gingras developed and identified new ones as well. These new proteins will be experimented on to determine their roles in tumor suppression and metastasis.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
279433
Name
Go Christopher D
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Mass spectrometry proteomic analysis of PTPN12 to elucidate its phosphatase role in tumor suppression and cell signalling
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cell Lines And Tumorigenicity Assay; Mass Spectrometry Proteomics; Tissue Culture; Triple Negative Breast Cancer
Abstract
PTPN12 is a phosphatase protein can cause cells to become tumorigenic when it is not working properly. It is found to be defective in patients with triple negative breast cancer, a type of breast cancer disease that is not easily identified by specific biomarkers and affects 20% of breast cancer patients. In addition, this particular breast cancer is highly aggressive and resistant to treatment. Better understanding of PTPN12 and its function in cellular biology will allow elucidation on how normal cells become cancerous. This project will focus primarily on triple negative breast cancer but the information gleaned from the research could very well apply to other cancers as well.
One method to determine how PTPN12 functions in cellular biology is to see what other proteins it affects and interacts with. To do this, we apply a new technique called BioID that fused our protein of interest with a biotin ligase. This protein essentially allows neighbouring proteins of PTPN12 to be covalently linked with a biotin molecule. This physical linkage allows the proteins, which are those that interact with PTPN12, to be isolated and from the cell using streptavidin, which binds to biotin molecules with extremely high affinity. The purified proteins are then subjected to mass spectrometry analysis to identify them. This method allows the discovery of new, unknown proteins that were not reported to interact with PTPN12. Early results show that this method identifies known protein interactors from an established purification method that the Gingras developed and identified new ones as well. These new proteins will be experimented on to determine their roles in tumor suppression and metastasis.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Go, Christopher D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~